NCT04339764View on ClinicalTrials.gov

Autologous Transplantation of Induced Pluripotent Stem Cell-Derived Retinal Pigment Epithelium for Geographic Atrophy Associated With Age-Related Macular Degeneration

PHASE1/PHASE2RecruitingINTERVENTIONAL
Enrollment

20

Participants

Timeline

Start Date

September 23, 2020

Primary Completion Date

May 31, 2029

Study Completion Date

May 31, 2029

Conditions
Dry Age-Related Macular DegenerationGeographic Atrophy
Interventions
DRUG

iPSC-derived RPE/PLGA transplantation

iPSC-derived RPE/PLGA transplantation

Trial Locations (2)

20892

RECRUITING

National Institutes of Health Clinical Center, Bethesda

21205

NOT_YET_RECRUITING

Johns Hopkins University, Baltimore

All Listed Sponsors
lead

National Eye Institute (NEI)

NIH